Trial Profile
The study to assess the association between saxagliptin use and acute myocardial infarction (AMI).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Nov 2017
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary) ; Pioglitazone; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Nov 2017 New trial record
- 09 Nov 2017 Results assessing the association between saxagliptin use and acute myocardial infarction (AMI), were published in the Diabetes Care.